Related Experiment Videos
VASA is a specific marker for both normal and malignant human germ cells
Anne-Marie Zeeman1, Hans Stoop, Marjan Boter
1Department of Pathology/Laboratory for Experimental Patho-Oncology, University Hospital of Rotterdam/Daniel, Josephine Nefkens Institute, Erasmus University Rotterdam, The Netherlands.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|February 19, 2002
Summary
VASA gene expression is specific to germ cells. This study found VASA in seminomas and precursor lesions, but not in non-seminomatous germ cell tumors, suggesting VASA is a biomarker for specific germ cell tumors.
Area of Science:
- Reproductive Biology
- Oncology
- Molecular Biology
Background:
- VASA is the sole known mammalian gene exclusively expressed in germ cells.
- Germ cell tumors (GCTs) exhibit diverse histological subtypes and origins.
- Understanding germ cell-specific markers is crucial for accurate tumor classification.
Purpose of the Study:
- To investigate VASA mRNA and protein presence in various GCTs and non-GCTs.
- To determine if VASA expression can differentiate between GCT subtypes.
- To evaluate VASA as a potential biomarker for germ cell neoplasia.
Main Methods:
- Quantitative reverse transcription-polymerase chain reaction (RT-PCR) for VASA mRNA detection.
- Immunohistochemical staining for VASA protein localization and intensity.
- Analysis of normal spermatogenesis, various GCTs, and non-GCTs.
Main Results:
- VASA mRNA and protein were detected in normal spermatogenesis, seminoma, carcinoma in situ, dysgerminoma, and gonadoblastoma.
- VASA expression was significantly lower in seminomas/dysgerminomas compared to spermatocytic seminomas.
- VASA was absent in nonseminomatous GCTs (embryonal carcinoma, teratoma, yolk sac tumor) and non-GCTs (lymphoma, Leydig cell tumor).
- Precursor lesions showed higher VASA staining intensity than their invasive counterparts.
Conclusions:
- VASA expression is retained in certain GCTs, indicating persistent germ cell characteristics.
- The absence of VASA in nonseminomatous GCTs suggests differentiation and loss of germ cell identity.
- VASA serves as a highly specific biomarker for seminoma, dysgerminoma, and their precursor lesions.